Vifor Pharma (VIFN)

Executive Summary

Vifor Pharma AG researches, develops, produces, and markets pharmaceutical products in Switzerland, rest of Europe, the United States, and internationally. More Details


Trading at 77.9% below our estimate of its fair value

Earnings are forecast to grow 18.17% per year

Earnings grew by 61.9% over the past year

Risk Analysis

No risks detected for VIFN from our risk checks.

Snowflake Analysis

Flawless balance sheet with proven track record and pays a dividend.

Similar Companies

Search for a company to compare.